Finally, a No Cost GLP‑1 Benefit Program

Big savings for employees, no cost for employers.

Improve outcomes and control PMPM. $200/month access for eligible members, no employer expense, with clinician support, GLP‑1 delivery, and ongoing support. Employer outcome reporting and savings analysis (de‑identified).

HIPAA‑aligned practices and BAAs available. Program reporting is de‑identified.

Wnat to learn more?

Trusted by leading employers and brokers

HIPAA‑aligned practices BAAs available De‑identified employer reporting SOC 2 controls

Join employers saving up to $8,520 per patient on a GLP‑1

Advisors, become a partner

Co‑market our Overlay Plan and $200/month GLP‑1 Program. We provide collateral, workflows, and rollout playbooks.

Deliver savings for all your employers with our unique program.

The AsOne Partners Corporate GLP-1 Weight Loss Program

The financial costs of GLP-1 receptor agonists (GLP-1s) for insurance companies or self-funded employers can be broken down into short-term and long-term impacts. These costs are driven by the high price of GLP-1s, increasing utilization, and their effects on healthcare spending related to obesity and comorbidities. Short-Term Financial Costs (1-3 Years)

High Drug Acquisition Costs-

  • GLP-1s like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) cost $500-$1,300 per month per patient, translating to $6,000-$16,000 annually.

  • In 2023, GLP-1 use cost employer health plans $6.25 per member per month, a 224% increase from 2022, with costs expected to rise further in 2025 due to growing demand.

Our Corporate GLP-1 can provide these important medications at the cost of their current copay & no employer cost

ü No employer expense

ü For all size employers 1 employee and up. Self-funded or Fully-Insured.

ü As low as $200/mo to employee

ü Includies clinic visits, care plan and medications delivered to the home.

ü Available to full time and part time employees and family members

ü Reduces chronic illness burden, reducing future rate increases from your carrier.

Calculate Your Savings Now

Typical adoption
5%–12%
Across covered lives
Expected PMPM impact
$10–$35
Conservative modeled range
Annual savings example
$150k–$450k
Employer with 400 covered lives
Drivers
Lower med costs, fewer sick days, clinical PMPM improvement

See your savings

Eligibility: 12%
Traditional: $910/mo per participant
AsOne program: $230/mo per participant
No PHI collected

Understanding the Impact of Obesity in the Workplace

Corporate America, we have a problem.

According to the National Health and Nutrition Examination Survey, 40.3% of U.S. adults are obese with prevalence climbing to 46.4% for adults 40-59. Moreover, obesity in working adults is linked to significant healthcare costs and comorbidities that impact both individuals and employers.

Comorbidities & Impact

Obesity drives higher prevalence and cost across chronic conditions. Click a condition to see prevalence by age and how weight loss changes the curve. Sources

3× risk
+ $2.0k–$4.5k PMPY
2× risk
+ $800–$1.8k PMPY
3–4× risk
+ $1.5k–$3.0k PMPY
1.5–2× risk
+ $1.2k–$2.5k PMPY
1.5–2× risk
+ $900–$1.9k PMPY
1.5–2× risk
+ $700–$1.6k PMPY
1.5–2× risk
+ $500–$1.2k PMPY
1.5–2× risk
+ $1.0k–$2.0k PMPY
1.5–2× risk
+ $2.5k–$5.0k PMPY
1.2–1.5× risk
+ $3.0k–$7.0k PMPY

Ranges are directional and vary by population mix and plan design.

FAQS

How much can my employees save?

AsOne Partners GLP-1 program can cost as low as $200 per month, often this is lower than the copay on a brand name program.

How much can I save as an employer?

The program can provide substantial savings for employers. If you have employees currently on GLP ones for diabetes or weight loss, you can save as much as $700.00 per Patient per month. If you have PBM reporting, take a look at your spend on these medication. it is possible to save that entire amount, often over $10,000 per patient per year.

I don't have many employees using these medications, why should I consider adding it?

According to the National Health and Nutrition Examination Survey, 40.3% of U.S. adults are obese with prevalence climbing to 46.4% for adults 40-59. Moreover, obesity in working adults is linked to significant healthcare costs and comorbidities that impact both individuals and employers.

Whether you have members using these medications at this time or not, you should add the program to support employees looking to consider such medications before they add them with your current carrier. Since there is no cost to the employer, it is a benefit addition that has tremendous health benefits.

When can I add this for my employees?

As a non-insurance discount program, you can add the program at any time.

How many employees do I need to have for the program?

The program is available for companies of any size (including Gig Workers and sole proprietors) and there is no minimum number of employees. If you can help just one employee get healthier at no cost to you, why wouldn't you?

What do I as the employer need to do to support the program?

Very little. Connect with us to get your discount code and employee materials and share these materials with your employees. If you are interested in rewarding employees, we can help you assess cost sharing options and FSA/HRA options. Additional reporting and outcome packages are available.

Who is eligible?

That is up to you. If you are not cost sharing, the GLP-1 program can be extended to all employees (including those that waive your traditional medical plan offering), all dependents, friends and family.

How do I learn more and get started?

Just email us at [email protected] and we will get you set up.

A New Approach to Corporate Wellness

A no cost option for employers

The Good News?

Help Is On the Way.

Having been responsible for 1 million members and over $3 billion in health care costs, we have experience that can assist you, or your broker, in benefit programs that are not routinely made available for employers. We deliver immediate, guaranteed savings without changing your medical plan. Best of all, these savings can start within 45 days, helping your bottom line immediately.

Some of the Many Benefits of GLP-1s


Significant Weight Loss- GLP-1s promote sustained weight loss by reducing appetite and increasing satiety. Clinical trials show 10-20% body weight reduction (e.g., 15-20 kg for a 100 kg person) over 1-2 years, far surpassing lifestyle interventions alone. Benefit for working adults: Improved physical mobility, reduced fatigue, and enhanced workplace productivity due to less physical strain.

Improved Glycemic Control- GLP-1s enhance insulin secretion and reduce glucagon levels, lowering blood sugar in type 2 diabetes. They reduce HbA1c by 1-2% on average. Benefit for working adults: Decreased risk of diabetes-related complications (e.g., neuropathy, retinopathy), reducing absenteeism and healthcare costs.


Cardiovascular Risk Reduction- GLP-1s lower the risk of major cardiovascular events (e.g., heart attack, stroke) by 12-26% in high-risk patients.

Sleep Apnea- Weight loss from GLP-1s reduces obstructive sleep apnea severity in 40-60% of cases, improving sleep quality and daytime alertness.

Osteoarthritis- Reduced joint stress from weight loss alleviates pain and improves mobility, with studies reporting 20-30% improvement in joint function.

Non-Alcoholic Fatty Liver Disease (NAFLD)- GLP-1s improve liver fat content and inflammation, with 30-40% of patients showing reduced liver fibrosis.

Mental Health- Weight loss and improved physical health correlate with a 10-15% reduction in depression and anxiety symptoms.

Blood Pressure and Lipid Profile Improvement- GLP-1s reduce systolic blood pressure by 2-5 mmHg and improve lipid profiles (e.g., 5-10% reduction in LDL cholesterol).

Potential Cancer Risk Reduction- By addressing obesity, GLP-1s may indirectly lower the risk of obesity-related cancers (e.g., colorectal, breast), though long-term data is still emerging.

Enhanced Workplace Productivity- Weight loss and comorbidity management lead to fewer missed workdays (1-3 days/year reduction) and improved focus, with studies estimating a 5-10% productivity boost.

The Bad News? GLP-1s can be Unaffordable, or Unavailable.

The financial costs of GLP-1 receptor agonists (GLP-1s) for insurance companies or self-funded employers can be broken down into short-term and long-term impacts. These costs are driven by the high price of GLP-1s, increasing utilization, and their effects on healthcare spending related to obesity and comorbidities. Short-Term Financial Costs (1-3 Years)

High Drug Acquisition Costs-

• GLP-1s like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) cost $500-$1,300 per month per patient, translating to $6,000-$16,000 annually.

• In 2023, GLP-1 use cost employer health plans $6.25 per member per month, a 224% increase from 2022, with costs expected to rise further in 2025 due to growing demand.

• Medicare Part D spending on GLP-1s jumped from $57 million in 2018 to $5.7 billion in 2022, a 100-fold increase in just four years, reflecting rapid cost escalation.

Increased Utilization-

• Utilization for diabetes rose 15.6% and for weight loss spiked 78% in 2024 compared to 2023. About 1.7% of employer-sponsored plan members used GLP-1s for obesity in 2022, doubling costs that year.

Premium and Cost-Sharing Strain-

• Employer healthcare costs are projected to rise 8-9% in 2025, partly due to GLP-1s, leading to higher premiums (e.g., $3,040 per person annually) and cost-sharing for employees.

• Only 34% of corporate plans cover GLP-1s for non-diabetic weight loss (up from 26% in 2023), but limited coverage still drives significant costs for insurers due to high per-patient expenses.

What’s the Solution? The AsOne Partner

Corporate GLP-1 Program.

Our GLP-1 program provides a comprehensive, patient-focused weight loss program that leverages GLP-1 medications to help individuals manage appetite, reduce hunger, and achieve sustainable weight loss. The program is designed to be accessible, transparent, and personalized, with a focus on expert medical guidance and convenience through telehealth.

Key Components of the Program

GLP-1 Medications Offered:

Semaglutide: A clinically proven GLP-1 receptor agonist (found in brand names like Ozempic and Wegovy) that supports weight loss by promoting satiety, slowing gastric emptying, and reducing appetite.

Tirzepatide: A newer GLP-1 and GIP receptor agonist (found in Mounjaro and Zepbound), noted for enhanced weight loss effects due to its dual-hormone action.

Personalized Treatment Plans:

Online Medical Intake: Patients submit their health history and weight loss goals via an online form. A board-certified physician reviews the information to create a customized treatment plan.

Metabolic Lab Testing: In some cases, the physician may require a metabolic lab test to assess eligibility and ensure safe prescribing, tailoring the approach to the patient’s medical needs.

Flexible Options: The program accommodates individual preferences, such as offering oral formulations for those averse to injections, and adjusts dosages based on patient response and goals.


Telehealth Consultations: Patients undergo quick and easy online consultations from home, where a licensed medical provider assesses their goals, discusses the treatment plan, and prescribes the appropriate GLP-1 medication.

The telehealth model eliminates the need for in-person visits, making it accessible for working adults with busy schedules.

Medication Delivery: Prescribed GLP-1 medications are shipped directly to the patient’s doorstep at no additional cost. Our pharmacy network ensures careful handling to maintain medication quality.

Both injectable and oral compounded forms are delivered, with clear instructions for use.

Ongoing Support and Monitoring: Regular Check-Ins: the provider schedules periodic virtual check-ins to monitor progress, adjust dosages, and address any concerns, ensuring patients stay on track.

On-Demand Medical Support: Patients have access to specialists for guidance throughout their weight loss journey, enhancing adherence and outcomes.

Expert Guidance: The program is overseen by professionals like Dr. Ruth Cohen, our Medical Director, ensuring high-quality care.

Transparent Pricing: There are no hidden fees, no gimmicks, and no shipping costs. Pricing covers medication, consultations, and ongoing support at all dosage levels. With the corporate Discount Program, the cost for the medication, telehealth visit, care plan and ongoing support is as little as $200 per month, often less expensive than the copay on branded medications (while you the employer can pay an additional $1,000 or more each month.

Convenience: The 100% online platform, free shipping, and oral options cater to busy working adults, reducing barriers to treatment.

Comprehensive Care: Combining expert medical oversight, regular monitoring, and tailored plans addresses both short-term weight loss and long-term health goals.

What is the Business Case for Employers?

Turn an Expensive and Often Unavailable Treatment Into a Valued Employee Benefit, At Little to No-Cost


Many Health Plans and Insurance Carriers are adding difficult approval processes, denying coverage for GLP-1s or making it cost prohibitive for both the employer and the employee. There is a better way.

With our GLP-1 Program you can

1. Help your employees regain their health and vibrancy.

2. Help employees reduce their future health care cost and reduce their chronic illness burden.

3. Potentially reduce your future rate increases or health care claims expense

Benefit Options

Option 1: Offer the AsOne Partner Corporate GLP-1 Program at no cost to you. Help your employees save money while getting healthier. No cost, no effort, just share the program information with employees as needed

Option 2: If needed, we have developed a turn-key Flexible Spending Account (FSA) option that employers can add at any time to reduce the cost for employees by up to 30% while saving up to $219 per employee in FICA expenses. The administration of the program has no net annual fee to the employer (after FICA savings) if six or more participants place an average of $200 per month in the Flexible Spending Account.

Option 3: Consider a flat contribution or a fixed copay approach ($0- $100+ per month per employee) toward health care expenses within a Health Reimbursement Account (HRA) to encourage employee engagement while rewarding employees for improving their heath. By making the Weight Loss program affordable for employees, they are more likely to engage and have success, potentially reducing overall medical expenses.

Of course, additional customization is available.

Data sources available upon request.

READY TO Help your employees with their weight loss journey?

Get Started for Free Today!

Connect with us now and ylet us show you how to reduce your health care costs while improving your employee's health today.

Who is AsOne Partners?

AsOne Partners has an extended team of experts available for any benefit need. We develop and promote innovative health care and insurance programs for employers and individuals.

Collaboration is at the heart of our team's philosophy. We work closely together and with you, our valued clients, to ensure that every aspect of your benefits program is thoughtfully designed, implemented, and managed. Your success is our success, and we are dedicated to going the extra mile to exceed your expectations.